Cited by 115Adrenal and Paraganglionic TumorsMedical Imaging Techniques and ApplicationsNeuroendocrine Tumor Research Advances

Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma

Mackie, Gavin C., Shulkin, Barry L., Ribeiro, Raul C., Worden, Francis P., Gauger, Paul G., Mody, Rajen J., Connolly, Len P., Kunter, Ghada +4 more·2006·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Adrenocortical carcinomas are uncommon, and their evaluation by [(18)F]fluorodeoxyglucose positron emission tomography (FDG PET) has not been well evaluated. OBJECTIVE: The purpose of this study was to examine the potential utility of FDG PET in the detection of recurrent or metastatic adrenocortical carcinoma. DESIGN: In patients with known adrenocortical carcinoma who underwent FDG-PET imaging for suspected recurrence or metastasis, FDG activity was compared with other imaging findings, clinical features, and the presence or absence of disease as confirmed by resection, biopsy, or clinical follow-up. SETTING: The study took place at four tertiary referral centers. PATIENTS OR OTHER PARTICIPANTS: Twelve patients (10 females and two males, 5-71 yr of age) were evaluated. MAIN OUTCOME MEASURES: The main outcome measures were FDG activity, other imaging findings, and clinical features. RESULTS: Abnormal FDG uptake correctly indicated tumor recurrence in 10 patients. One patient with no abnormal FDG activity had a morphological abnormality subsequently proven to be a postoperative scar. Two patients, one with very small pulmonary lesions and one with a hepatic metastasis, had false-negative findings. CONCLUSIONS: Most adrenocortical carcinomas accumulate and retain FDG and thus can be visualized by PET. However, false-negative findings are possible, especially with very small lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2005-2612

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intensity of FDG uptake is related to survival in patients with ACC, with a maximum SUV of >10 indicating poor prognosis.

    “Intensity of FDG uptake was found to be related to survival in patients with ACC, with a maximum SUV of >10 indicating poor prognosis (111).”

    From Adrenocortical carcinoma (2014) · cites this paper as [111]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., Hurwitz, C. A., & Schteingart, D. E.
Affiliations
  • University of Michigan (US)
  • St. Jude Children's Research Hospital (US)
  • Department of Internal Medicine, Divisions of Hematology-Oncology (F.P.W.) Ann Arbor, Michigan 48109
  • Department of Surgery (P.G.G.) Ann Arbor, Michigan 48109
  • Boston Children's Hospital (US)
  • Departments of Pediatrics (G.K.) St. Louis, Missouri 63110
  • Hematology-Oncology (R.C.R., C.R.-G.), St. Jude Children’s Research Hospital, Memphis, Tennessee 38105
  • Washington University in St. Louis (US)
  • Maine Medical Center (US)
  • Endocrinology and Metabolism (D.E.S.) Ann Arbor, Michigan 48109
Corresponding author
Shulkin, Barry L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2006-07-01
Volume
91
Issue
7
Pages
2665-2671
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2146827226
Cited by
115
References
29
Citations by year
2024: 5 · 2023: 6 · 2022: 9 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 6 · 2012: 8
FWCI
7.14
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Lebanese Syrian Associated Charities
  • U.S. Public Health Service
  • National Cancer Institute (5R25 CA 23944, CA54216, CA21765, R25CA023944, P30CA021765)
  • National Center for Research Resources (M-01RR00042, M01RR000042)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
Keywords
adrenocortical carcinoma, FDG-PET, tumor recurrence, metastasis detection, false-negative results, small pulmonary lesions, liver metastasis, postoperative scar
MeSH terms
Adrenal Cortex Neoplasms, Adult, Aged, Child, Child, Preschool, False Negative Reactions, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review